All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

Approximately one quarter of the world population is estimated to have latent tuberculosis infection (LTBI) \[[@pone.0221081.ref001]\]. At this stage, infected subjects do not experience clinical symptoms and are not contagious. However they have a 5--10% life-time risk of developing active tuberculosis (TB) \[[@pone.0221081.ref002]\], which is most pronounced during the early stage of infection \[[@pone.0221081.ref003]\], thereby also becoming an important source of TB contagion. LTBI screening in targeted populations is thus pivotal in order to prevent the spread of TB. Healthcare workers (HCWs) have a higher risk of contracting TB than the general population through occupational exposure \[[@pone.0221081.ref004]\]. Several studies have investigated the prevalence of and the risk factors for LTBI in HCWs \[[@pone.0221081.ref004]--[@pone.0221081.ref007]\] in countries highly endemic for TB. Reported pooled prevalences ranged from 37 to 63% in these recent meta-analyses \[[@pone.0221081.ref004]--[@pone.0221081.ref007]\] with a variability depending on important factors such as countries' income, Bacillus Calmette-Guérin (BCG) vaccination coverage, and LTBI status definition.

The diagnosis of LTBI is inferred indirectly from quantitative measurements of anti-mycobacterial immunity, attesting to induction of acquired immunity to *Mycobacterium tuberculosis* \[[@pone.0221081.ref008]\]. The tuberculin skin test (TST) is done *in vivo* and consists of an intradermal injection of purified protein derivative (PPD) that provokes a delayed hypersensitivity reaction at the site of injection. It is a sensitive test widely used but it lacks specificity, partly due to cross-reactions with BCG, and, to a lesser extent, non-tuberculous mycobacteria \[[@pone.0221081.ref009]\]. Another type of tests, interferon-gamma release assays (IGRAs), are performed *in vitro* and detect the secretion of interferon-gamma (IFN-γ) by leukocytes that recognize *M*. *tuberculosis*-specific antigens. In particular, the QuantiFERON-TB Gold In-Tube test (QFT-GIT) is based on the specific *M*. *tuberculosis* antigens ESAT-6, CFP10 and TB7.7 (Qiagen, Hilden, Germany). The specificity of these tests is higher than TST and is not affected by BCG vaccination \[[@pone.0221081.ref010]\]. IGRA results are not fully concordant with TST findings, but they provide complementary information about infection status \[[@pone.0221081.ref011]--[@pone.0221081.ref013]\]. The World Health Organization recommends tailored LTBI management based on tuberculosis burden and resource availability using either the TST or IGRAs \[[@pone.0221081.ref014]\]. However, the performance of the two tests is not known in some specific settings. In this study, we investigated the prevalence and risk factors for LTBI assessed by both IGRAs and TST in HCWs from Morocco, a low-middle-income country with an intermediate annual incidence of TB (99/100,000 in 2017), and high BCG vaccination coverage \[[@pone.0221081.ref015]--[@pone.0221081.ref016]\].

Materials and methods {#sec002}
=====================

Study design and population {#sec003}
---------------------------

A cross-sectional study was conducted from March 2012 to September 2016 in two Moroccan cities, Rabat and Meknes. HCWs were recruited from two hospitals, the Military Hospital Mohammed V of Rabat and the Military Hospital Moulay Ismail of Meknes. During the four years period of enrollment, the TB incidence in Morocco was stable around 100/100,000. We included in the study all adult HCWs with an age between 18 and 60 years who accepted to participate. Exclusion criteria were ongoing pregnancy, immunosuppressive treatment, history of clinical TB disease, known chronic HIV, hepatitis B or C infections, as well as known cancer or chronic renal failure. Information on the following variables was obtained using a questionnaire: gender, age, comorbidities such as diabetes or asthma (yes/no), smoking status (yes/no), history of TB in family members (yes/no), BCG vaccination, working area and occupation. The working area variable consisted of four relevant categories: non-clinical department (such as administrative sectors or laboratories, with indirect exposure to patients), surgical department (direct exposure to patients but low risk of airborne transmission), clinical department (direct exposure to patients) and the pulmonology unit (direct exposure to high-risk patients). The occupation variable was divided into three categories: the non-medical staff (such as administrative personnel, secretaries), the paramedical staff (lab technicians and auxiliaries), and the medical staff (physicians and nurses). All HCWs declared to have been vaccinated with BCG at birth. The sample size was determined by the number of HCWs who fulfilled the inclusion criteria and responded favorably to the questionnaire. The study was approved by the ethics committee of the Faculty of Medicine of Casablanca, Morocco. Written informed consent was obtained from each participant.

QuantiFERON-TB Gold In-Tube test (QFT-GIT) assays {#sec004}
-------------------------------------------------

QFT-GIT testing was performed on blood samples collected before the TST was carried out, in accordance with the kit manufacturer's instructions. Briefly, 1 ml of peripheral blood was drawn directly into each of three blood collection tubes under vacuum: the nil tube or negative control, the mitogen tube containing phytohaemagglutinin or positive control and the TB specific antigen tube containing specific antigens (early secretory antigenic target 6, culture filtrate protein 10 and TB 7.7 antigen) for *M*. *tuberculosis*. The contents of each tube were mixed and the tubes were incubated at 37°C for 16 to 24 hours within 16 hours of collection. Then they were centrifuged at 2500 rpm for 15 minutes at room temperature. The supernatant was stored at -20°C. The concentration of IFN-γ in each sample was determined by QFT-GIT ELISA (enzyme-linked immunosorbent assay) kit. QFT-GIT results, calculated as TB antigen minus nil value (IU/mL), were categorized as positive (≥0.35 IU/mL, QFT+), negative (\<0.35 IU/mL, QFT-) or indeterminate following the software provided by the manufacturer. To further investigate discordant results with TST, QFT-GIT results were sub-classified as strong negative (\<0.2 IU/mL), weak negative (0.2--0.34 IU/mL), weak positive (0.35--0.7 IU/mL) and strong positive (\>0.7 IU/mL) \[[@pone.0221081.ref017]--[@pone.0221081.ref018]\].

Tuberculin skin test {#sec005}
--------------------

The tuberculin skin test (TST) was performed by the medical staff, in accordance with routine hospital procedure. Two units of standardized purified protein derivative (PPD) solution (2 T.U Tuberculin PPD RT 23, Statens Serum Institut, Copenhagen, Denmark) were injected intradermally into the forearm of all the participants using the Mantoux method. Results were evaluated after 72 hours of the intradermal injection. The transversal diameter of the induration was measured in millimeters. We considered three different cut-offs (≥ 5, 10 and 15 mm) for a positive result (TST+) to compare with QFT-GIT results. Based on our agreement results, previous studies in similar settings \[[@pone.0221081.ref005]\] and published guidelines \[[@pone.0221081.ref019]\], the 10 mm cut-off was used to assess LTBI risk factors.

Statistical analysis {#sec006}
--------------------

The concordance between QFT-GIT and TST results was calculated as the number of double positive (QFT+/TST+) plus double negative (QFT-/TST-) test results divided by the total number of test results. The agreement between QFT-GIT and TST results was also calculated using Cohen's kappa coefficient (κ) and its 95% confidence intervals (CIs). Fisher's exact test was used to compare the proportion of QFT-GIT subcategories between concordant QFT/TST and discordant QFT/TST results. The TST induration between QFT-/TST+ and QFT+/TST+ results and between QFT+/TST- and QFT-/TST- was compared using Mann-Whitney test. We assessed the risk factors associated with TB infection using five different definitions of the LTBI status: (i) QFT+ vs. QFT-, (ii) TST+ vs. TST-, (iii) QFT+/TST+ vs. QFT-/TST-, (iv) discordant TST positive QFT-/TST+ vs. QFT-/TST- and (v) discordant QFT-GIT positive QFT+/TST- vs. QFT-/TST-. All analyses were conducted with a univariable and a multivariable mixed-effects logistic regression with a random effect per hospital to investigate the risk factors associated with LTBI. Statistical significance was considered to be a p-value under 0.05. All analyses were carried out using R software (version 3.4.0) and related packages "psych" and "lme4" \[[@pone.0221081.ref020]--[@pone.0221081.ref022]\].

Results {#sec007}
=======

Healthcare workers {#sec008}
------------------

A total of 662 healthy HCWs were recruited from the hospitals of Rabat (n = 328) and Meknes (n = 334). We excluded 31 participants because of an indeterminate QFT-GIT result. Baseline characteristics of the 631 HCWs with reliable QFT-GIT results are displayed in [Table 1](#pone.0221081.t001){ref-type="table"}. Overall, 54% of HCWs were male (n = 341), 47.1% were younger than 35 years old (n = 297) and 44.1% of them worked in a non-clinical department (n = 278). The majority of HCWs belonged to the medical staff (n = 321, 50.9%). The prevalence of QFT positivity was 40.7% (95%CI 36.9--44.5%) and that of TST positivity at the 10 mm cut-off was 52.1% (95%CI 48.2--56.0%) ([Fig 1](#pone.0221081.g001){ref-type="fig"}). When considering the LTBI status among individuals with concordant positive (QFT+/TST+) and concordant negative (QFT-/TST-) results, the prevalence of QFT+/TST+ was 45.2% (95%CI 40.7--49.5%).

10.1371/journal.pone.0221081.t001

###### Baseline characteristics of 631 healthcare workers.

![](pone.0221081.t001){#pone.0221081.t001g}

  Characteristics            n (%)
  -------------------------- ------------
  Gender                     
   Male                      341 (54.0)
   Female                    290 (46.0)
  Age group (years)          
   18--34                    297 (47.1)
   35--44                    186 (29.5)
   45--60                    148 (23.4)
  Comorbidities              
   No                        586 (92.9)
   Yes                       45 (7.1)
  Smoking status             
   No                        549 (87.0)
   Yes                       82 (13.0)
  Family history of TB       
   No                        588 (93.2)
   Yes                       43 (6.8)
  Work area                  
   Non-clinical department   278 (44.0)
   Surgical department       118 (18.7)
   Clinical department       184 (29.2)
   Pulmonology unit          51 (8.1)
  Occupation                 
   Non-medical staff         167 (26.4)
   Paramedical staff         143 (22.7)
   Medical staff             321 (50.9)
  QFT-GIT                    
   Negative                  374 (59.3)
   Positive                  257 (40.7)
  TST                        
   \<10 mm                   302 (47.9)
   ≥10 mm                    329 (52.1)

QFT-GIT: QuantiFERON-TB Gold In-Tube; TB: tuberculosis; TST: tuberculin skin test

![Scatterplot of quantitative QuantiFERON-TB Gold In-Tube (QFT-GIT) and tuberculin skin test (TST) results of 631 healthcare workers.\
The horizontal red dashed line represents a QFT-GIT cut-off of 0.35 IU/mL and the vertical one a TST cut-off of 10 mm. Samples with a QFT-GIT TB Antigen value inferior to the nil value were truncated to 0 (n = 122) and samples with a QFT-GIT TB Antigen value \> 10 IU/mL were truncated to 10 (n = 63). One sample had a QFT-GIT TB Antigen minus nil value superior to 0.35 IU/mL but inferior to 25% of the nil value leading to a negative test result.](pone.0221081.g001){#pone.0221081.g001}

Agreement between QFT-GIT and TST results {#sec009}
-----------------------------------------

The agreement between QFT-GIT and TST results was slightly higher with a 10 mm TST cut-off \[κ = 0.50; 95%CI 0.43--0.56; concordance of 74.6%\] than with a 5 mm cut-off \[κ = 0.48; 95%CI 0.41--0.54; concordance of 72.7%\] or a 15 mm cut-off \[κ = 0.44; 95%CI 0.37--0.51; concordance of 73.3%\] ([Table 2](#pone.0221081.t002){ref-type="table"}). Therefore, we kept the 10 mm cut-off for all further analyses on TST.

10.1371/journal.pone.0221081.t002

###### Agreement between QFT-GIT and TST results in 631 healthcare workers according to various TST cut-offs (5 mm, 10 mm and 15 mm).

![](pone.0221081.t002){#pone.0221081.t002g}

                   TST 5 mm            TST 10 mm           TST 15 mm
  ---------------- ------------------- ------------------- -------------------
  QFT-/TST-        226                 258                 303
  QFT+/TST+        233                 213                 160
  QFT-/TST+        148                 116                 71
  QFT+/TST-        24                  44                  97
  Concordance, %   72.7                74.6                73.3
  Κappa (95% CI)   0.48 (0.41--0.54)   0.50 (0.43--0.56)   0.44 (0.37--0.51)

QFT-GIT: QuantiFERON-TB Gold In-Tube; TST: tuberculin skin test

We further investigated the levels of the QFT-GIT and TST results in discordant and concordant subjects ([S1 Table](#pone.0221081.s001){ref-type="supplementary-material"}). Among 374 HCWs with QFT- results, the proportion of weak negative QFT-GIT result (0.2--0.34 IU/mL) was significantly higher (p = 0.0005) in discordant QFT-/TST+ subjects (17/116, 14.7%) than in double negative QFT-/TST- subjects (10/258, 3.9%). When focusing on 257 HCWs with QFT+ results, we did not observe any significant difference in the proportions of weak positive QFT-GIT result (0.35--0.7 IU/mL) between discordant QFT+/TST- subjects (5/44, 11.4%) and double positive QFT+/TST+ subjects (26/213, 12.2%). Among 302 HCWs with TST- results, the median induration size was significantly higher (p = 3.10^−9^) in discordant QFT+/TST- subjects (median = 3 mm) than in double negative QFT-/TST- subjects (median = 0 mm). Finally, among 329 HCWs with TST+ results, the median induration size was significantly lower (p = 0.0002) in discordant QFT-/TST+ subjects (median = 15 mm) than in double positive QFT+/TST+ subjects (median = 17 mm).

Risk factors associated with LTBI status {#sec010}
----------------------------------------

When considering the LTBI status defined only by QFT-GIT results, univariable analyses showed that QFT+ was significantly associated with male gender (OR = 2.14; 95%CI 1.54--2.97, p = 6.10^−6^), older age between 35--44 years (OR = 1.80; 95%CI 1.23--2.63; p = 0.003) and 45--60 years (OR = 3.02; 95%CI 1.99--4.57; p = 2.10^−7^), smoking (OR = 2.57; 95%CI 1.59--4.15; p = 0.0001) and family history of TB (OR = 3.16; 95%CI 1.63--6.12; p = 0.0007). All these variables remained significant in multivariable analysis ([Table 3](#pone.0221081.t003){ref-type="table"}).

10.1371/journal.pone.0221081.t003

###### Risk factors associated with a positive QFT-GIT result in 631 healthcare workers.

![](pone.0221081.t003){#pone.0221081.t003g}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                  Total\    QFT-\     QFT+\     OR~uni~[^a^](#t003fn002){ref-type="table-fn"} (95%CI)   p~uni~[^b^](#t003fn003){ref-type="table-fn"}   OR~mult~[^c^](#t003fn004){ref-type="table-fn"} (95%CI)   p~mult~[^d^](#t003fn005){ref-type="table-fn"}
                             n = 631   n = 374   n = 257                                                                                                                                                                   
  -------------------------- --------- --------- --------- ------------------------------------------------------- ---------------------------------------------- -------------------------------------------------------- -----------------------------------------------
  Gender                                                                                                                                                                                                                   

   Female                    290       200       90        Ref                                                                                                    Ref                                                      

   Male                      341       174       167       **2.14 (1.54--2.97)**                                   **6.10**^**−6**^                               **1.69 (1.17--2.46)**                                    **0.006**

  Age group (years)                                                                                                                                                                                                        

   18--34                    297       207       90        Ref                                                                                                    Ref                                                      

   35--44                    186       104       82        **1.80 (1.23--2.63)**                                   **0.003**                                      **1.57 (1.04--2.37)**                                    **0.03**

   45--60                    148       63        85        **3.02 (1.99--4.57)**                                   **2.10**^**−7**^                               **2.74 (1.74--4.31)**                                    **1.10**^**−5**^

  Comorbidities                                                                                                                                                                                                            

   No                        586       348       238       Ref                                                                                                    Ref                                                      

   Yes                       45        26        19        1.08 (0.58--1.99)                                       0.82                                           0.95 (0.49--1.85)                                        0.88

  Smoking status                                                                                                                                                                                                           

   No                        549       342       207       Ref                                                                                                    Ref                                                      

   Yes                       82        32        50        **2.57 (1.59--4.15)**                                   **0.0001**                                     **1.89 (1.12--3.21)**                                    **0.02**

  Family history of TB                                                                                                                                                                                                     

   No                        588       360       228       Ref                                                                                                    Ref                                                      

   Yes                       43        14        29        **3.16 (1.63--6.12)**                                   **0.0007**                                     **3.41 (1.70--6.85)**                                    **0.0006**

  Work area                                                                                                                                                                                                                

   Non-clinical department   278       160       118       Ref                                                                                                    Ref                                                      

   Surgical department       118       79        39        0.94 (0.64--1.38)                                       0.74                                           1.40 (0.84--2.34)                                        0.19

   Clinical department       184       106       78        0.68 (0.43--1.07)                                       0.10                                           0.73 (0.41--1.27)                                        0.26

   Pulmonology unit          51        29        22        1.09 (0.59--2.01)                                       0.77                                           1.80 (0.88--3.69)                                        0.11

  Job category                                                                                                                                                                                                             

   Non-medical staff         167       89        78        Ref                                                                                                    Ref                                                      

   Paramedical staff         143       80        63        0.91 (0.58--1.43)                                       0.68                                           1.00 (0.58--1.74)                                        0.99

   Medical staff             321       205       116       0.65 (0.44--1.05)                                       0.10                                           0.70 (0.41--1.19)                                        0.19
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CI: confidence interval; QFT-GIT: QuantiFERON-TB Gold In-Tube; TB: tuberculosis

^a^OR~uni~: odds ratio obtained in a univariable regression

^b^p~uni~: p-value corresponding to the coefficient obtained in a univariable regression

^c^OR~mult~: odds ratio obtained in a multivariable regression including all the variables explored in univariable analyses

^d^p~mult~: p-value corresponding to the coefficient obtained in a multivariable regression including all the variables explored in univariable analyses

Bold text indicates a statistically significant result

When the LTBI status was defined only by TST, the same variables as those found in the previous analysis were significantly associated with TST+ in univariable analysis, with an additional one corresponding to working at a pulmonology unit (OR = 2.31; 95%CI 1.21--4.40; p = 0.01) ([Table 4](#pone.0221081.t004){ref-type="table"}). In multivariable analysis, male gender (OR = 1.70; 95%CI 1.15--2.51; p = 0.008), older age between 35--44 years (OR = 2.80; 95%CI 1.82--4.30; p = 3.10^−6^) or 45--60 years (OR = 3.68; 95%CI 2.26--5.99; p = 2.10^−7^), family history of TB (OR = 4.89; 95%CI 2.04--11.74; p = 0.0004) and working at a pulmonology unit (OR = 3.79; 95%CI 1.77--8.13; p = 0.0006\] were still associated with TST+. However smoking was no more a risk factor when adjusting for other covariates (OR = 1.27; 95%CI 0.71--2.26; p = 0.42) in particular gender, probably explained by the fact that all smokers were males (n = 82).

10.1371/journal.pone.0221081.t004

###### Risk factors associated with a positive TST result in 631 healthcare workers.

![](pone.0221081.t004){#pone.0221081.t004g}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                  Total\    TST-\     TST+\     OR~uni~[^a^](#t004fn002){ref-type="table-fn"} (95%CI)   p~uni~[^b^](#t004fn003){ref-type="table-fn"}   OR~mult~[^c^](#t004fn004){ref-type="table-fn"} (95%CI)   p~mult~[^d^](#t004fn005){ref-type="table-fn"}
                             n = 631   n = 302   n = 329                                                                                                                                                                   
  -------------------------- --------- --------- --------- ------------------------------------------------------- ---------------------------------------------- -------------------------------------------------------- -----------------------------------------------
  Gender                                                                                                                                                                                                                   

   Female                    290       165       125       Ref                                                                                                    Ref                                                      

   Male                      341       137       204       **2.10 (1.50--2.94)**                                   **2.10**^**−5**^                               **1.70 (1.15--2.51)**                                    **0.008**

  Age group (years)                                                                                                                                                                                                        

   18--34                    297       185       112       Ref                                                                                                    Ref                                                      

   35--44                    186       73        113       **2.58 (1.74--3.84)**                                   **3.10**^**−6**^                               **2.80 (1.82--4.30)**                                    **3.10**^**−6**^

   45--60                    148       44        104       **3.50 (2.25--5.45)**                                   **3.10**^**−8**^                               **3.68 (2.26--5.99)**                                    **2.10**^**−7**^

  Comorbidities                                                                                                                                                                                                            

   No                        586       280       306       Ref                                                                                                    Ref                                                      

   Yes                       45        32        23        0.98 (0.52--1.85)                                       0.95                                           0.82 (0.41--1.65)                                        0.58

  Smoking status                                                                                                                                                                                                           

   No                        549       273       276       Ref                                                                                                    Ref                                                      

   Yes                       82        29        53        **1.83 (1.10--3.05)**                                   **0.02**                                       1.27 (0.71--2.26)                                        0.42

  Family history of TB                                                                                                                                                                                                     

   No                        588       294       294       Ref                                                                                                    Ref                                                      

   Yes                       43        8         35        **4.04 (1.79--9.10)**                                   **0.0008**                                     **4.89 (2.04--11.74)**                                   **0.0004**

  Work area                                                                                                                                                                                                                

   Non-clinical department   278       144       134       Ref                                                                                                    Ref                                                      

   Surgical department       118       57        61        1.07 (0.72--1.59)                                       0.75                                           1.41 (0.83--2.41)                                        0.21

   Clinical department       184       81        103       1.28 (0.81--2.02)                                       0.29                                           1.29 (0.73--2.29)                                        0.39

  Pulmonology unit           51        20        31        **2.31 (1.21--4.40)**                                   **0.01**                                       **3.79 (1.77--8.13)**                                    **0.0006**

  Job category                                                                                                                                                                                                             

   Non-medical staff         143       60        83        Ref                                                                                                    Ref                                                      

   Paramedical staff         167       82        85        1.46 (0.91--2.35)                                       0.12                                           1.51 (0.84--2.71)                                        0.17

   Medical staff             321       160       161       1.02 (0.69--1.51)                                       0.93                                           1.07 (0.61--1.88)                                        0.81
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CI: confidence interval; TB: tuberculosis; TST: tuberculin skin test

^a^OR~uni~: odds ratio obtained in a univariable regression

^b^p~uni~: p-value corresponding to the coefficient obtained in a univariable regression

^c^OR~mult~: odds ratio obtained in a multivariable regression including all the variables explored in univariable analyses

^d^p~mult~: p-value corresponding to the coefficient obtained in a multivariable regression including all the variables explored in univariable analyses

Bold text indicates a statistically significant result

We then considered a more stringent definition of the LTBI status by focusing on the double positive QFT+/TST+ (n = 213) vs. the double negative QFT-/TST- subjects (n = 258). The same risk factors as those identified in the previous analysis focusing on TST only were found to be significantly associated with LTBI in a multivariable analysis ([Table 5](#pone.0221081.t005){ref-type="table"}): being a male (OR = 2.21; 95%CI 1.40--3.49; p = 0.0007), having an older age between 35--44 years (OR = 2.43; 95%CI 1.45--4.06; p = 0.0007) or 45--60 years (OR = 4.81; 95%CI 2.72--8.52; p = 7.10^−8^), family history of TB (OR = 6.62; 95%CI 2.59--16.94; p = 8.10^−5^) and working at a pulmonology unit (OR = 3.64; 95%CI 1.44--9.23; p = 0.006). Again, smoking was not a significant risk factor for QFT+/TST+ when adjusting for other covariates (OR = 1.83; 95%CI 0.90--3.74; p = 0.10).

10.1371/journal.pone.0221081.t005

###### Risk factors from multivariable regressions associated with positive concordant results (QFT+/TST+) results compared to the reference group (negative concordant results QFT-/TST-) in healthcare workers.

![](pone.0221081.t005){#pone.0221081.t005g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                  Total\    QFT-\     QFT+\     OR~mult~[^a^](#t005fn002){ref-type="table-fn"} (95%CI)   p~mult~[^b^](#t005fn003){ref-type="table-fn"}
                             n = 471   TST-\     TST+\                                                              
                                       n = 258   n = 213                                                            
  -------------------------- --------- --------- --------- -------------------------------------------------------- -----------------------------------------------
  Gender                                                                                                            

   Female                    229       152       77        Ref                                                      

   Male                      242       106       136       **2.21 (1.40--3.49)**                                    **0.0007**

  Age group (years)                                                                                                 

   18--34                    245       170       75        Ref                                                      

   35--44                    121       56        65        **2.43 (1.45--4.06)**                                    **0.0007**

   45--60                    105       32        73        **4.81 (2.72--8.52)**                                    **7.10**^**−8**^

  Comorbidities                                                                                                     

   No                        440       241       199       Ref                                                      

   Yes                       31        17        14        0.80 (0.34--1.91)                                        0.62

  Smoking status                                                                                                    

   No                        414       240       174       Ref                                                      

   Yes                       57        18        39        1.83 (0.90--3.74)                                        0.10

  Family history of TB                                                                                              

   No                        436       251       185       Ref                                                      

   Yes                       35        7         28        **6.62 (2.59--16.94)**                                   **8.10**^**−5**^

  Work area                                                                                                         

   Non-clinical department   204       115       89        Ref                                                      

   Surgical department       90        54        36        1.46 (0.78--2.72)                                        0.23

   Clinical department       43        73        70        0.87 (0.44--1.72)                                        0.68

   Pulmonology unit          34        16        18        **3.64 (1.44--9.23)**                                    **0.006**

  Job category                                                                                                      

   Non-medical staff         118       61        57        Ref                                                      

   Paramedical staff         107       52        55        1.31 (0.66--2.62)                                        0.44

   Medical staff             246       145       101       0.82 (0.43--1.56)                                        0.54
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------

CI: confidence interval; QFT: QuantiFERON-TB Gold In-Tube; TB: tuberculosis; TST: tuberculin skin test

^a^OR~mult~: odds ratio obtained in a multivariable regression including all the variables explored in univariable analyses

^b^p~mult~: p-value corresponding to the coefficient obtained in a multivariable regression including all the variables explored in univariable analyses

Bold text indicates a statistically significant result

Risk factors associated with discordant QFT-GIT and TST results {#sec011}
---------------------------------------------------------------

Finally, we performed a specific analysis on the individuals with discordant results, QFT-/TST+ (n = 116) and QFT+/TST- (n = 44) that we compared to QFT-/TST- subjects (n = 258) ([Table 6](#pone.0221081.t006){ref-type="table"}). For QFT-/TST+ individuals, we obtained in multivariable analysis results similar to those observed when considering all TST+ subjects with significant associations for male gender (OR = 1.73; 95% CI: 1.02--2.93; p = 0.04), older age between 35--44 years (OR = 4.18; 95%CI: 2.34--7.44; p = 1.10^−6^) or 45--60 years (OR = 4.35; 95%CI 2.16--8.75; p = 2.10^−7^) and working at a pulmonology unit (OR = 3.95; 95%CI 1.43--10.88; p = 0.008) without any effect of smoking (OR = 0.98; 95%CI 0.40--2.38; p = 0.97).

10.1371/journal.pone.0221081.t006

###### Risk factors from multivariable regressions associated with discordant results (QFT-/TST+, QFT+/TST-) compared to the reference group (negative concordant results QFT-/TST-) in healthcare workers.
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  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                  QFT-\     QFT-\     OR~mult~[^a^](#t006fn002){ref-type="table-fn"} (95%CI)   p~mult~[^b^](#t006fn003){ref-type="table-fn"}   QFT+\    OR~mult~^a^ (95%CI)     p~mult~[^b^](#t006fn003){ref-type="table-fn"}
                             TST-\     TST+\                                                                                                              TST-\                            
                             n = 258   n = 116                                                                                                            n = 44                           
  -------------------------- --------- --------- -------------------------------------------------------- ----------------------------------------------- -------- ----------------------- -----------------------------------------------
  Gender                                                                                                                                                                                   

   Female                    152       48        Ref                                                                                                      13       Ref                     

   Male                      106       68        **1.73 (1.02--2.93)**                                    **0.04**                                        31       **2.37 (1.07--5.25)**   **0.03**

  Age group (years)                                                                                                                                                                        

   18--34                    170       37        Ref                                                                                                      15       Ref                     

   35--44                    56        48        **4.18 (2.34--7.44)**                                    **1.10**^**−6**^                                17       2.41 (0.99--5.88)       0.05

   45--60                    32        31        **4.35 (2.16--8.75)**                                    **4.10**^**−5**^                                12       **3.17 (1.18--8.50)**   **0.02**

  Comorbidities                                                                                                                                                                            

   No                        241       107       Ref                                                                                                      39                               

   Yes                       17        9         0.90 (0.35--2.36)                                        0.84                                            5        1.23 (0.35--4.40)       0.75

  Smoking status                                                                                                                                                                           

   No                        240       102       Ref                                                                                                      33       Ref                     

   Yes                       18        14        0.98 (0.40--2.38)                                        0.97                                            11       **3.35 (1.17--9.60)**   **0.02**

  Family history of TB                                                                                                                                                                     

   No                        251       109       Ref                                                                                                      43       Ref                     

   Yes                       7         7         1.89 (0.52--6.91)                                        0.33                                            1        1.65 (0.18--15.56)      0.66

  Work area                                                                                                                                                                                

   Non-clinical department   115       45        Ref                                                                                                      29       Ref                     

   Surgical department       54        25        1.27 (0.60--2.66)                                        0.53                                            3        0.80 (0.83--2.41)       0.68

   Clinical department       73        33        1.22 (0.56--2.67)                                        0.62                                            8        **0.17 (0.04--0.72)**   **0.02**

   Pulmonology unit          16        13        **3.95 (1.43--10.88)**                                   **0.008**                                       4        1.70 (0.43--6.72)       0.46

  Job category                                                                                                                                                                             

   Non-medical staff         61        28        Ref                                                                                                      21       Ref                     

   Paramedical staff         52        28        1.56 (0.69--3.55)                                        0.29                                            8        0.85 (0.29--2.53)       0.78

   Medical staff             145       60        1.22 (0.55--2.68)                                        0.62                                            15       0.54 (0.20--1.49)       0.24
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CI: confidence interval; QFT: QuantiFERON-TB Gold In-Tube; TB: tuberculosis; TST: tuberculin skin test

^a^OR~mult~: odds ratio obtained in a multivariable regression including all the variables explored in univariable analyses

^b^p~mult~: p-value corresponding to the coefficient obtained in a multivariable regression including all the variables explored in univariable analyses

Bold text indicates a statistically significant result

For QFT+/TST- individuals, we observed in multivariable analysis results close to those with the QFT+ analysis, with less significant p-values due to the smaller sample size. An association was observed with male gender (OR = 2.37; 95%CI 1.07--5.25; p = 0.03), older age which is borderline non-significant for the group 35--44 years (OR = 2.41; 95%CI 0.99--5.88; p = 0.05) and significant for the group 45--60 years (OR = 3.17; 95%CI 1.18--8.50; p = 0.02) and smoking (OR = 3.35; 95%CI 1.17--9.60; p = 0.02). We also noted a protective effect of working at a clinical department (OR = 0.17; 95%CI 0.04--0.72; p = 0.02).

Discussion {#sec012}
==========

We report here the first study of LTBI conducted in HCWs from Morocco, a middle-income country with intermediate endemicity for TB and high BCG vaccination coverage. The prevalence of LTBI ranged from 40.7% (36.9--44.5%) with QFT+ to 52.1% (48.2--56.0%) with TST+ and was 45.2% (40.7--49.5%) when considering the double positive QFT+/TST+ status. These values are consistent with prevalences observed in HCWs living in high TB burden countries such as Brazil (37%), China (54%), and India (43%) \[[@pone.0221081.ref006]\]. The higher proportion of TST+ compared to QFT+ in Morocco is consistent with a meta-analysis showing the same pattern in 24 out of 25 studies comparing IGRAs with TST in HCWs \[[@pone.0221081.ref023]\]. This observation may be explained in part by the higher specificity of IGRAs \[[@pone.0221081.ref009]\], and an extensive BCG vaccination coverage as it is the case in Morocco. The overall agreement between QFT-GIT and TST results (κ = 0.50 at a 10 mm cut-off) was also similar to previous estimates in high TB incidence countries (κ = 0.38 in a recent meta-analysis ranging from 0.19 in China to 0.61 in India \[[@pone.0221081.ref024]\]).

Interestingly, we identified risk factors that were consistently associated with LTBI, whatever its definition, namely gender, age, and familial history of TB. Male gender is a well-known risk factor for active TB disease due at least in part to socio-cultural causes as well as biological differences between sexes \[[@pone.0221081.ref025]--[@pone.0221081.ref026]\] but this gender disparity has not been fully investigated for LTBI. A significant higher proportion of LTBI in adult men than in adult women was reported in several studies \[[@pone.0221081.ref027]--[@pone.0221081.ref029]\] except one in a moderate TB burden country (Taiwan) that did not find gender as a risk factor while taking into account potential confounders \[[@pone.0221081.ref030]\]. The increase of LTBI prevalence with age is a well-known observation which has been previously reported either with QFT-GIT \[[@pone.0221081.ref031]--[@pone.0221081.ref032]\] or TST \[[@pone.0221081.ref033]\]. In our study, age was extremely correlated with the length of employment as almost all HCWs in military hospitals are recruited when they are young adults (between 18--21 years). Therefore, the increased risk of LTBI in the age groups belonging to 35--44 and 45--60 years is probably explained by a longer cumulative exposure that could be occupational and/or non-occupational.

We also identified other risk factors that reflect a close contact to infectious TB patients either through household exposure with a family TB history or an occupational one as working at a pulmonology unit, as already reported \[[@pone.0221081.ref027],[@pone.0221081.ref031],[@pone.0221081.ref034]\]. Beside the work area, we did not find any association with the job category and other potential occupational exposures may have not been captured. We also observed some interesting effects related to smoking. First, the smoking effect observed in univariable analyses decreased (QFT-GIT) or disappeared (TST) when adjusting for other covariates, in particular gender, probably because all smokers were males. In addition, when defining LTBI status by QFT-GIT, the smoking effect appeared to be stronger when considering discordant QFT+/TST- than concordant QFT+/TST+. Smoking was previously reported to be a risk factor for LTBI when assessed by QFT-GIT and/or TST \[[@pone.0221081.ref027]--[@pone.0221081.ref028],[@pone.0221081.ref035]\], and also to affect the performance of the QFT-GIT test itself \[[@pone.0221081.ref036]\]. Further specific investigations should be conducted to investigate the relationship between smoking and IGRAs results with particular attention to confounding factors such as age, gender or socioeconomic status.

Finally, we focused on the discordant results between the two tests. As expected, QFT-/TST+ results were more frequent (116/631, 18.4%) than QFT+/TST- (44/631, 7.0%) \[[@pone.0221081.ref023]\]. The QFT-/TST+ discordance is often attributed in part to BCG vaccination and non-tuberculous mycobacteria. Interestingly, QFT-/TST+ subjects shared the same risk factors as those identified in the analysis for the QFT+/TST+ subjects. Moreover, we found a stronger proportion of weak negative QFT-GIT results in QFT-/TST+ than in QFT-/TST- (14.7% vs. 3.9%) indicating that some of these individuals may have a negative result due to the substantial variability of IGRA tests \[[@pone.0221081.ref010]\]. We also observed that the proportion of QFT-/TST+ was higher (79/334, 23.7%) in the oldest age group 35--60 years, when compared with the younger age group 18--34 (37/297, 12.5%) ([S2 Table](#pone.0221081.s002){ref-type="supplementary-material"}), consistent with the view that discordant QFT-/TST+ results may be due in part to temporally more remote infections \[[@pone.0221081.ref037]\]. Regarding the other discordant group QFT+/TST-, we also observed risk factors similar to those obtained with the QFT+ outcome, and this group had larger TST reactions than those of the QFT-/TST- group. Also, we cannot exclude that some of these QFT+/TST- subjects displayed a complete nonspecific cutaneous anergy that may explain a negative TST \[[@pone.0221081.ref038]\]. All these observations suggest that a substantial proportion of QFT+/TST- and QFT-/TST+ discordant HCWs may be truly infected individuals. Overall, the results we observed in terms of prevalence and risk factors for LTBI in HCWs living in Morocco were similar when using TST or QFT-GIT, suggesting that either could be used for a screening.
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###### Comparison of discordant QFT-/TST+ vs. double negative QFT-/TST- results and QFT+/TST- vs. double positive QFT+/TST+ results according to QFT-GIT TB antigen minus nil categories.
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###### Agreement between QFT-GIT and TST results in 631 healthcare workers according to age category and a TST cut-off at 10 mm.
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